|
Volumn 298, Issue 2, 2001, Pages 461-468
|
Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CASPASE 3;
CYTOCHROME C;
DNA NUCLEOTIDYLEXOTRANSFERASE;
DOXORUBICIN;
FLUORESCEIN ISOTHIOCYANATE;
LIPOCORTIN 5;
METALLOTHIONEIN;
REACTIVE OXYGEN METABOLITE;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
CELL CULTURE;
CONFOCAL MICROSCOPY;
CONTROLLED STUDY;
ENZYME ACTIVATION;
ENZYME RELEASE;
HEART INJURY;
HEART MUSCLE CELL;
HEART PROTECTION;
MITOCHONDRION;
MOUSE;
NICK END LABELING;
NONHUMAN;
OXIDATIVE STRESS;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
WESTERN BLOTTING;
ANIMALS;
ANIMALS, NEWBORN;
ANNEXIN A5;
ANTIBIOTICS, ANTINEOPLASTIC;
APOPTOSIS;
CASPASE 3;
CASPASES;
CYTOCHROME C GROUP;
DOXORUBICIN;
ENZYME ACTIVATION;
FLUORESCEIN-5-ISOTHIOCYANATE;
IN SITU NICK-END LABELING;
L-LACTATE DEHYDROGENASE;
METALLOTHIONEIN;
MICE;
MICE, TRANSGENIC;
MITOCHONDRIA, HEART;
MYOCARDIUM;
REACTIVE OXYGEN SPECIES;
|
EID: 0034913884
PISSN: 00223565
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (175)
|
References (33)
|